Does dabigatran increase the risk of delayed hematoma expansion in a rat model of collagenase-induced intracerebral hemorrhage?

Journal of Stroke and Cerebrovascular Diseases

Volumn 24, Issue 2, 2015, Pages 374-380

  Tanoue, Shunsuke ^a,b   Inamasu, Joji ^a   Yamada, Masayuki ^a   Toyama, Hiroshi ^a   Hirose, Yuichi ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Department of Obstetrics and Gynecology   (Japan)

Author keywords

Dabigatran; delayed hematoma expansion; intracerebral hemorrhage; magnetic resonance imaging; warfarin

Indexed keywords

COLLAGENASE; DABIGATRAN ETEXILATE; ANTITHROMBIN; BENZIMIDAZOLE DERIVATIVE; BETA ALANINE; DABIGATRAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CONTROLLED STUDY; MALE; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; RISK FACTOR; VOLUMETRY; ANALOGS AND DERIVATIVES; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; HEMATOMA; PATHOLOGY; TIME; WISTAR RAT;

ANIMALS; ANTITHROMBINS; BENZIMIDAZOLES; BETA-ALANINE; CEREBRAL HEMORRHAGE; COLLAGENASES; DISEASE MODELS, ANIMAL; HEMATOMA; MALE; RATS; RATS, WISTAR; TIME FACTORS;

EID: 84922849116     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2014.09.010     Document Type: Article

References (24)

1. S. Uchiyama, S. Ibayashi, and M. Matsumoto Dabigatran and factor Xa inhibitors for stroke prevention in patients with nonvalvular atrial fibrillation J Stroke Cerebrovasc Dis 21 2012 165 173
2. K. Toyoda, M. Yasaka, and S. Uchiyama CHADS2 and CHA2DS2-VASc scores as bleeding risk indices for patients with atrial fibrillation: the Bleeding with Antithrombotic Therapy Study Hypertens Res 37 2014 463 466
3. S. Ogawa, Y. Koretsune, and M. Yasaka Antithrombotic therapy in atrial fibrillation: evaluation and positioning of new oral anticoagulant agents Circ J 75 2011 1539 1547
4. J.J. Flibotte, N. Hagan, and J. O'Donnell Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage Neurology 63 2004 1059 1064
5. R.G. Hart, B.S. Boop, and D.C. Anderson Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses Stroke 26 1995 1471 1477
6. S.B. Lee, E.M. Manno, and K.F. Layton Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP Neurology 67 2006 1272 1274
7. G.A. Rosenberg, S. Mun-Bryce, and M. Wesley Collagenase-induced intracerebral hemorrhage in rats Stroke 21 1990 801 807
8. C.L. MacLellan, G. Silasi, and C.C. Poon Intracerebral hemorrhage models in rat: comparing collagenase to blood infusion J Cereb Blood Flow Metab 28 2008 516 525
9. J. van Ryn, J. Stangier, and S. Haertter Dabigatran etexilate: a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity Thromb Haemost 103 2010 1116 1127
10. M.R. Del Bigio, H.J. Yan, and R. Buist Experimental intracerebral hemorrhage in rats. Magnetic resonance imaging and histopathological correlates Stroke 27 1996 2312 2319
11. W. Zhou, S. Schwarting, and S. Illanes Hemostatic therapy in experimental intracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran Stroke 42 2011 3594 3599
12. X.N. Tang, A.E. Berman, R.A. Swanson, and M.A. Yenari Digitally quantifying cerebral hemorrhage using Photoshop and Image J J Neurosci Methods 190 2010 240 243
13. R.G. Hart, H.C. Diener, and S. Yang Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial Stroke 43 2012 1511 1517
14. A. Lauer, F.A. Cianchetti, and E.M. Van Cott Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage Circulation 124 2011 1654 1662
15. T. Baglin, D. Keeling, and S. Kitchen Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: guidance from the British Committee for Standards in Haematology Br J Haematol 159 2012 427 429
16. W. Wienen, J.M. Stassen, and H. Priepke Effects of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate, on thrombus formation and bleeding time in rats Thromb Haemost 98 2007 333 338
17. W. Pfeilschifter, F. Bohmann, and P. Baumgarten Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke Ann Neurol 71 2012 624 633
18. T. Sakata, K. Kario, and T. Matsuo Suppression of plasma-activated factor VII levels by warfarin therapy Arterioscler Thromb Vasc Biol 15 1995 241 246
19. H. Matsushita, M. Hijioka, and A. Hisatsune MRI-based analysis of intracerebral hemorrhage in mice reveals relationship between hematoma expansion and the severity of symptoms PLoS One 8 2013 e67691 10.1371/journal.pone.0067691
20. M. Li, R.M. Akhavan-Sharif, and R.M. Friedlander What sequences on high-field MR best depict temporal resolution of experimental ICH and edema formation in mice? J Biomed Biotechnol 2012 2012 961461
21. J. Inamasu, M. Oheda, and T. Hayashi Are admission systolic blood pressures predictive of outcomes in patients with spontaneous intracerebral haemorrhage after aggressive blood pressure management? Eur J Emerg Med 2014 Feb 19 [Epub ahead of print]
22. M. Komori, M. Yasaka, and K. Kokuba Intracranial hemorrhage during dabigatran treatment Circ J 78 2014 1335 1341
23. C.Z. Simonsen, T. Steiner, and A. Tietze Dabigatran-related intracerebral hemorrhage resulting in hematoma expansion J Stroke Cerebrovasc Dis 23 2014 e133 e134
24. C. Foerch, K. Arai, and G. Jin Experimental model of warfarin-associated intracerebral hemorrhage Stroke 39 2008 3397 3404